BRKR Bruker Corporation
BRKR Bruker Corporation
Healthcare · Medical Devices
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 bull converging
POC $38.86 · VWAP $48.49 · +13.0% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster VP, President sold $312.8K, Aug 18
Coverage
1 watchlist
BRKR Price Structure
Loading timeframes…
Peers
Every watchlist BRKR belongs to, members best 30-day change first — BRKR highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
Reported the quarter ending 2026-06-30: revenue $839M, diluted EPS -$0.41, net income -$52M (SEC filing). Across the print the stock moved -18.4% (close before → first close after).
full note →Against street estimates
How BRKR's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about BRKR from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 30 days ago · Sep 17
BRKR research tape
66 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.